Sunday, 22 April 2018 - 0:02
  • it
  • de
  • en
  • fr

Rheumatoid arthritis

Sanofi’s Kevzara approved in US for rheumatoid arthritis

Sanofi and Regeneron jointly announced that FDA approved Kevzara (sarilumab) for the treatment of rheumatoid arthritis. Kevzara is a monoclonal antibody that binds to the interleukin-6 receptor (IL-6R), and helps reduce the inflammation. Rheumatoid arthritis is a disease affecting millions…

The European Commission gives new indications on BMS’ Orencia

The European Commission has extended the authorization of BMS’ Orencia (abatacept) for intravenous and subcutaneous administration, in combination with methotrexate, for the treatment of adult patients with highly active and progressive rheumatoid arthritis, not previously treated with methotrexate. Orencia is…